Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071331
Status:
COMPLETED
Last Update Posted:
2012-05-03
First Post:
2003-10-20
Brief Title:
EVEREST Efficacy of Vasopressin Antagonism in hEart failuRE Outcome Study With Tolvaptan
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Organization Data
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Class:
INDUSTRY
Study ID:
156-03-236
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None